You are here

Article Text

Article menu
Download PDFPDF
Letters
Audit on the uptake of influenza and pneumococcal vaccination in patients with rheumatoid arthritis
  1. John Pradeep,
  2. Richard Watts,
  3. Gavin Clunie
  1. Department of Rheumatology, Ipswich Hospital, Ipswich, UK
  1. Correspondence to:
    Dr J Pradeep
    Department of Rheumatology, Ipswich Hospital, NHS Trust, Ipswich NR4 7UY, UK; drjohnpd{at}btinternet.com

https://doi.org/10.1136/ard.2006.060285

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    According to the Department of Health guidelines in the UK, patients who are immunosuppressed should be vaccinated against influenza and pneumococcal infection.1 There are now convincing data regarding the efficacy of vaccination and use of disease-modifying antirheumatic drugs (DMARDs) in patients with rheumatoid arthritis (RA).2–,5 There is evidence from other countries that the uptake of vaccination is suboptimal, especially in those aged <65 years.6

    We undertook a study in patients attending our clinics to establish (1) vaccination uptake in our patients who are immunosuppressed, and (2) the reasons if patients had not received the influenza or pneumococcal (pneumovax) vaccination.

    We collected data from 155 consecutive patients attending our clinics during March …

    View Full Text

    Footnotes

    • Competing interests: None.